Shifting Medicare Part B drugs to Part D saves nothing, CBO says

A Congressional Budget Office analysis of the Trump administration’s FY19 budget proposal concludes that authorizing the HHS secretary to shift drugs from Medicare Part B to D would not produce

Read the full 307 word article

User Sign In